This code represents a SARS–CoV–2 vaccine product (tris–sucrose formulation) administered by intramuscular injection to reduce the patient’s risk of contracting COVID–19. The dosage is 3 mcg/0.3 mL.
For clinical responsibility, terminology, tips and additional info
start codify free trial.